NCT01803074View on ClinicalTrials.gov

Study to Evaluate a HIV Drug for the Treatment of HIV Infection

PHASE2CompletedINTERVENTIONAL

Enrollment

107

Participants

Timeline

Start Date

April 4, 2013

Primary Completion Date

November 29, 2014

Study Completion Date

November 29, 2014

Conditions

Infection, Human Immunodeficiency VirusHIV Infections

Interventions

DRUG

BMS-955176

BMS-955176

DRUG

Placebo matching with BMS-955176

Placebo matching with BMS-955176

DRUG

Atazanavir

Atazanavir

DRUG

Ritonavir

Ritonavir

DRUG

Tenofovir

Tenofovir

DRUG

Emtricitabine

Emtricitabine

Trial Locations (1)

13353

GSK Investigational Site, Berlin

Sponsors

Lead Sponsor

ViiV Healthcare

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

ViiV Healthcare

INDUSTRY